Current status of cancer genome medicine for pancreatic ductal adenocarcinoma

Toshifumi Doi, Takeshi Ishikawa, Michihisa Moriguchi, Yoshito Itoh

Open source

DOI
10.1093/jjco/hyaf012
Published
2025-02-02
Container
Japanese Journal of Clinical Oncology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jjco/hyaf012,
  title = {Current status of cancer genome medicine for pancreatic ductal adenocarcinoma},
  author = {Toshifumi Doi and Takeshi Ishikawa and Michihisa Moriguchi and Yoshito Itoh},
  year = {2025},
  journal = {Japanese Journal of Clinical Oncology},
  doi = {10.1093/jjco/hyaf012},
  url = {https://doi.org/10.1093/jjco/hyaf012}
}

RIS

TY  - JOUR
TI  - Current status of cancer genome medicine for pancreatic ductal adenocarcinoma
AU  - Toshifumi Doi
AU  - Takeshi Ishikawa
AU  - Michihisa Moriguchi
AU  - Yoshito Itoh
PY  - 2025
JO  - Japanese Journal of Clinical Oncology
DO  - 10.1093/jjco/hyaf012
UR  - https://doi.org/10.1093/jjco/hyaf012
ER  - 

APA

Doi, T., Ishikawa, T., Moriguchi, M., & Itoh, Y. (2025). Current status of cancer genome medicine for pancreatic ductal adenocarcinoma. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf012

Source records